Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.
- DOI
- 10.1016/j.maturitas.2026.109075
- Published
- 2026 Sep
- Container
- Maturitas
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.maturitas.2026.109075,
title = {Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.},
author = {Pinkerton JV and Simon JA and Panay N and Nappi RE and Brennan DJ and Donders G and Soares CN and Maki P and Caetano C and Haberland C and Laapas K and Zuurman L and Cardoso F},
year = {2026},
journal = {Maturitas},
doi = {10.1016/j.maturitas.2026.109075},
url = {https://doi.org/10.1016/j.maturitas.2026.109075}
}RIS
TY - JOUR TI - Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program. AU - Pinkerton JV AU - Simon JA AU - Panay N AU - Nappi RE AU - Brennan DJ AU - Donders G AU - Soares CN AU - Maki P AU - Caetano C AU - Haberland C AU - Laapas K AU - Zuurman L AU - Cardoso F PY - 2026 JO - Maturitas DO - 10.1016/j.maturitas.2026.109075 UR - https://doi.org/10.1016/j.maturitas.2026.109075 ER -
APA
JV, P., JA, S., N, P., RE, N., DJ, B., G, D., CN, S., P, M., C, C., C, H., K, L., L, Z., & F, C. (2026). Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.. Maturitas. https://doi.org/10.1016/j.maturitas.2026.109075
Source records
- pubmed · retrieved 2026-09-26T02:54:39.382Z